These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37861044)

  • 1. The Biological Function of POLA2 in Hepatocellular Carcinoma.
    Yang Z; Shen X; Wang Z; Li R; Hou W; Liu Z; Gao Y; Zhu C; Qin X
    Comb Chem High Throughput Screen; 2024; 27(12):1758-1775. PubMed ID: 37861044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma.
    Teng Y; Liu R
    Transl Cancer Res; 2024 Apr; 13(4):1848-1860. PubMed ID: 38737703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
    Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
    Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling.
    Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H
    J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
    Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
    Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
    Gao D; Li S; Guo H; Liu X; Liu Z; Li L; Bao L; Dang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):202. PubMed ID: 38812312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
    Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
    Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
    Li Y; Xiong H
    BMC Cancer; 2022 Mar; 22(1):298. PubMed ID: 35313850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of the role of LDHs subtype in pan-cancer demonstrates the importance of LDHD in the prognosis of hepatocellular carcinoma patients.
    Wang S; Wu X; Wu X; Cheng J; Chen Q; Qi Z
    BMC Cancer; 2024 Jan; 24(1):156. PubMed ID: 38291366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of SLCO4C1 as a biological marker in hepatocellular carcinoma based on anoikis classification features.
    Wang T; Guo K; Yang S; Zhang D; Cui H; Yin J; Yuan S; Wang Y; Qi Y; Wu W
    Aging (Albany NY); 2024 Jan; 16(2):1440-1462. PubMed ID: 38226966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
    Li N; Jiang S; Fu R; Lv J; Yao J; Mai J; Hua X; Chen H; Liu J; Lu M
    Biomark Med; 2021 Apr; 15(5):347-358. PubMed ID: 33666519
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
    Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
    BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
    Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma.
    Cheng X; Li D; Qi T; Sun J; Zhou T; Zheng WV
    Sci Rep; 2022 Jan; 12(1):211. PubMed ID: 34997064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.